Xiaoxiao Ma

5PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold, Lynda Vuong, Josef Leibold

|May 25, 2022
The Hippo pathway mediates Semaphorin signaling.

Zhipeng Meng, Fu-Long Li, Cao Fang

|Apr 09, 2021
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.

Robert M Samstein, Chirag Krishna, Xiaoxiao Ma

|Jun 05, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas.

Yuxiang Wang, Aaron T Wild, Sevin Turcan

|May 04, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.

Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee

Pageof 1

Frequent Collaborators

4 joint publications

Timothy A Chan

3 joint publications

Fengshen Kuo

2 joint publications

Robert M Samstein

2 joint publications

Luc Gt Morris